NCT06139029View on ClinicalTrials.gov

Comparison of 3% Normal Saline Nebulization Versus Steroid Nebulization in the Treatment of Bronchiolitis

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 15, 2022

Primary Completion Date

March 15, 2023

Study Completion Date

March 15, 2023

Conditions
Acute Bronchiolitis
Interventions
DRUG

3% normal saline

nebulization

DRUG

steroid(beclomethasone dipropionate 400 μg/day) and salbutamol with 0.9% normal saline

nebulization

Trial Locations (1)

Unknown

Faizan Sadiq, Mardan

Sponsors
All Listed Sponsors
lead

Mardan Medical Complex

OTHER

NCT06139029 - Comparison of 3% Normal Saline Nebulization Versus Steroid Nebulization in the Treatment of Bronchiolitis | Biotech Hunter | Biotech Hunter